Citations (153)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Shuqin Zhan, Hui Ye, Ning Li, Yimeng Zhang, Yueyang Cheng, Yuanqing Wang, Shimin Hu & Yue Hou. (2023) Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis. Nature and Science of Sleep 15, pages 217-230.
Read now
Read now
Marilyn Huckans, Stephen Boyd, Grant Moncrief, Nathan Hantke, Bethany Winters, Kate Shirley, Emily Sano, Holly McCready, Laura Dennis, Milky Kohno, William Hoffman & Jennifer M. Loftis. (2021) Cognition during active methamphetamine use versus remission. Journal of Clinical and Experimental Neuropsychology 43:6, pages 599-610.
Read now
Read now
Ashima S Sahni, Melissa Carlucci, Malik Malik & Bharati Prasad. (2019) Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects. Nature and Science of Sleep 11, pages 241-252.
Read now
Read now
Ulf Kallweit & Claudio L. Bassetti. (2017) Pharmacological management of narcolepsy with and without cataplexy. Expert Opinion on Pharmacotherapy 18:8, pages 809-817.
Read now
Read now
Ramalingam Vetrivelan, Clifford B Saper & Patrick M Fuller. (2014) Armodafinil-induced wakefulness in animals with ventrolateral preoptic lesions. Nature and Science of Sleep 6, pages 57-63.
Read now
Read now
Geert Mayer, Claudio LA Bassetti & Yves Dauvilliers. (2013) Treatment options in narcolepsy. Expert Opinion on Orphan Drugs 1:12, pages 987-999.
Read now
Read now
Martin McElhiney, Judith Rabkin, Wilfred Van Gorp & Richard Rabkin. (2013) Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue. Journal of Clinical and Experimental Neuropsychology 35:7, pages 718-727.
Read now
Read now
Peter Niemegeers, Kristof E Maudens, Manuel Morrens, Lisbeth Patteet, Leen Joos, Hugo Neels & Bernard GC Sabbe. (2012) Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1189-1197.
Read now
Read now
Mark
D. Allen, Dawson
W. Hedges, Thomas
J. Farrer & Michael
J. Larson. (2012) Assessment of brain activity during memory encoding in a narcolepsy patient on and off modafinil using normative fMRI data. Neurocase 18:1, pages 13-25.
Read now
Read now
Gbolagade Sunmaila Akintomide & Hugh Rickards. (2011) Narcolepsy: a review. Neuropsychiatric Disease and Treatment 7, pages 507-518.
Read now
Read now
Russell Rosenberg & Richard Bogan. (2010) Armodafinil in the treatment of excessive sleepiness. Nature and Science of Sleep 2, pages 95-105.
Read now
Read now
David E McCarty. (2010) Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag. Nature and Science of Sleep 2, pages 85-94.
Read now
Read now
Jonathan RL Schwartz, Thomas Roth & Chris Drake. (2010) Armodafinil in the treatment of sleep/wake disorders. Neuropsychiatric Disease and Treatment 6, pages 417-427.
Read now
Read now
Mia Zaharna, Alex Dimitriu & Christian Guilleminault. (2010) Expert opinion on pharmacotherapy of narcolepsy. Expert Opinion on Pharmacotherapy 11:10, pages 1633-1645.
Read now
Read now
Richard K Bogan. (2010) Armodafinil in the treatment of excessive sleepiness. Expert Opinion on Pharmacotherapy 11:6, pages 993-1002.
Read now
Read now
Vahid Mohsenin. (2009) Narcolepsy—Master of Disguise: Evidence-Based Recommendations for Management. Postgraduate Medicine 121:3, pages 99-104.
Read now
Read now
Michel Billiard. (2008) Narcolepsy: current treatment options and future approaches. Neuropsychiatric Disease and Treatment 4:3, pages 557-566.
Read now
Read now
Abid Bhat & Ali A El Solh. (2008) Management of narcolepsy. Expert Opinion on Pharmacotherapy 9:10, pages 1721-1733.
Read now
Read now
D Alan Lankford. (2008) Armodafinil: a new treatment for excessive sleepiness. Expert Opinion on Investigational Drugs 17:4, pages 565-573.
Read now
Read now
Articles from other publishers (134)
Petra Prochazkova, Karel Sonka, Radka Roubalova, Janet Jezkova, Sona Nevsimalova, Jitka Buskova, Radana Merkova, Tereza Dvorakova, Iva Prihodova, Simona Dostalova & Helena Tlaskalova-Hogenova. (2024) Investigation of anti-neuronal antibodies and disparity in central hypersomnias. Sleep Medicine 113, pages 220-231.
Crossref
Crossref
Margaret Blattner & Kiran Maski. (2023) Central Disorders of Hypersomnolence. CONTINUUM: Lifelong Learning in Neurology 29:4, pages 1045-1070.
Crossref
Crossref
Teris Cheung, Joyce Yuen Ting Lam, Kwan Hin Fong, Calvin Pak-Wing Cheng, Alex Ho, Julie Sittlington, Yu-Tao Xiang & Tim Man Ho Li. (2023) Evaluating the Efficacy of Electrical Vestibular Stimulation (VeNS) on Insomnia Adults: Study Protocol of a Double-Blinded, Randomized, Sham-Controlled Trial. International Journal of Environmental Research and Public Health 20:4, pages 3577.
Crossref
Crossref
Alessandro Zuddas & Sara Carucci. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
41
.
Po-Yu Chien, Chan-Yen Kuo, Meng-Hsuan Lin, Yao-Jen Chang & Chin-Chuan Hung. (2022) Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine 11:21, pages 6302.
Crossref
Crossref
Stephen Klaus, Aoife Carolan, Deirdre O'Rourke & Barry Kennedy. (2022) What respiratory physicians should know about narcolepsy and other hypersomnias. Breathe 18:3, pages 220157.
Crossref
Crossref
Nicholas-Tiberio Economou, Luigi Ferini-Strambi & Paschalis Steiropoulos. (2022) Sleep-Related Drug Therapy in Special Conditions. Sleep Medicine Clinics 17:3, pages 531-542.
Crossref
Crossref
Taisuke Ono, Shinichi Takenoshita & Seiji Nishino. (2022) Pharmacologic Management of Excessive Daytime Sleepiness. Sleep Medicine Clinics 17:3, pages 485-503.
Crossref
Crossref
Wei-Chih Chin, Chih-Huan Wang, Yu-Shu Huang, Jen-Fu Hsu, Kuo-Chung Chu, I Tang & Teresa Paiva. (2022) Quality of life changes and their predictors in young adult narcolepsy patients after treatment: A real-world cohort study. Frontiers in Psychiatry 13.
Crossref
Crossref
Yuen-Siang Ang, Cristina Cusin, Yoann Petibon, Daniel G Dillon, Micah Breiger, Emily L Belleau, Marc Normandin, Hans Schroder, Sean Boyden, Emma Hayden, M Taylor Levine, Aava Jahan, Ashley K Meyer, Min Su Kang, Devon Brunner, Steven E Gelda, Jacob Hooker, Georges El Fakhri, Maurizio Fava & Diego A Pizzagalli. (2022) A multi-pronged investigation of option generation using depression, PET and modafinil. Brain 145:5, pages 1854-1865.
Crossref
Crossref
Russell Rosenberg, Kimberly Babson, Diane Menno, Susan Morris, Michelle Baladi, Danielle Hyman & Jed Black. (2021) Test–retest reliability of the Epworth Sleepiness Scale in clinical trial settings. Journal of Sleep Research 31:2.
Crossref
Crossref
Kiran Maski, Emmanuel Mignot, Giuseppe Plazzi & Yves Dauvilliers. (2022) Disrupted nighttime sleep and sleep instability in narcolepsy. Journal of Clinical Sleep Medicine 18:1, pages 289-304.
Crossref
Crossref
Oki Ishikawa, Stella Hahn & Harly Greenberg. (2022) Pharmacologic Therapy for Narcolepsy. Neurology 18:1, pages 68.
Crossref
Crossref
Kimberly Johnson, Meghna P. Mansukhani & Bhanu Prakash Kolla. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
149
178
.
Kimberly Johnson, Meghna P. Mansukhani & Bhanu Prakash Kolla. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
179
199
.
Gerard J. Meskill, Craig W. Davis, Donna Zarycranski, Markiyan Doliba, Jean-Charles Schwartz & Jeffrey M. Dayno. (2021) Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials. CNS Drugs 36:1, pages 61-69.
Crossref
Crossref
Janet H. Dailey & Susmita Chowdhuri. 2022. Essentials of Sleep Medicine. Essentials of Sleep Medicine
21
46
.
Imran Ahmed & Michael Thorpy. 2022. Essentials of Sleep Medicine. Essentials of Sleep Medicine
327
348
.
Claudio L. A. Bassetti, Ulf Kallweit, Luca Vignatelli, Giuseppe Plazzi, Michel Lecendreux, Elisa Baldin, Leja Dolenc‐Groselj, Poul Jennum, Ramin Khatami, Mauro Manconi, Geert Mayer, Markku Partinen, Thomas Pollmächer, Paul Reading, Joan Santamaria, Karel Sonka, Yves Dauvilliers & Gert J. Lammers. (2021) European guideline and expert statements on the management of narcolepsy in adults and children. Journal of Sleep Research 30:6.
Crossref
Crossref
Kiran Maski, Lynn Marie Trotti, Suresh Kotagal, R. Robert Auger, Todd J. Swick, James A. Rowley, Sarah D. Hashmi & Nathaniel F. Watson. (2021) Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. Journal of Clinical Sleep Medicine 17:9, pages 1895-1945.
Crossref
Crossref
Claudio L. A. Bassetti, Ulf Kallweit, Luca Vignatelli, Giuseppe Plazzi, Michel Lecendreux, Elisa Baldin, Leja Dolenc‐Groselj, Poul Jennum, Ramin Khatami, Mauro Manconi, Geert Mayer, Markku Partinen, Thomas Pollmächer, Paul Reading, Joan Santamaria, Karel Sonka, Yves Dauvilliers & Gert J. Lammers. (2021) European guideline and expert statements on the management of narcolepsy in adults and children. European Journal of Neurology 28:9, pages 2815-2830.
Crossref
Crossref
Angela M. Anniss, Alan Young & Denise M. O’Driscoll. (2021) Microsleep assessment enhances interpretation of the Maintenance of Wakefulness Test. Journal of Clinical Sleep Medicine 17:8, pages 1571-1578.
Crossref
Crossref
Russell Rosenberg, Michelle Baladi & Morgan Bron. (2021) Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea. Journal of Clinical Sleep Medicine 17:4, pages 711-717.
Crossref
Crossref
Christian Franceschini, Fabio Pizza, Francesca Cavalli & Giuseppe Plazzi. (2021) A practical guide to the pharmacological and behavioral therapy of Narcolepsy . Neurotherapeutics 18:1, pages 6-19.
Crossref
Crossref
Alok Sachdeva. 2021. Sleep Disorders. Sleep Disorders
3
35
.
Hyun-Woo Kim & Jae Wook Cho. (2020) Narcolepsy, How do We Manage it?. Journal of Sleep Medicine 17:1, pages 1-10.
Crossref
Crossref
Shinichi Takenoshita & Seiji Nishino. (2020) Pharmacologic Management of Excessive Daytime Sleepiness. Sleep Medicine Clinics 15:2, pages 177-194.
Crossref
Crossref
Christian Franceschini, Fabio Pizza, Elena Antelmi, Maria Claudia Folli & Giuseppe Plazzi. (2019) Narcolepsy treatment: pharmacological and behavioral strategies in adults and children. Sleep and Breathing 24:2, pages 615-627.
Crossref
Crossref
Michael J. Thorpy & Richard K. Bogan. (2020) Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Medicine 68, pages 97-109.
Crossref
Crossref
Nicolas A. Nunez, Balwinder Singh, Francisco Romo‐Nava, Boney Joseph, Marin Veldic, Alfredo Cuellar‐Barboza, Alejandra Cabello Arreola, Jennifer L. Vande Voort, Paul Croarkin, Katherine M. Moore, Joanna Biernacka, Susan L. McElroy & Mark A. Frye. (2020) Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials. Bipolar Disorders 22:2, pages 109-120.
Crossref
Crossref
Helene A. Emsellem, Michael J. Thorpy, Gert Jan Lammers, Colin M. Shapiro, Geert Mayer, Giuseppe Plazzi, Dan Chen, Lawrence P. Carter, Kathleen F. Villa, Lawrence Lee, Diane Menno, Jed Black & Yves Dauvilliers. (2020) Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy. Sleep Medicine 67, pages 128-136.
Crossref
Crossref
Atul Malhotra, Colin Shapiro, Jean-Louis Pepin, Jaz Hedner, Mansoor Ahmed, Nancy Foldvary-Schaefer, Patrick J StrolloJrJr, Geert Mayer, Kathleen Sarmiento, Michelle Baladi, Patricia Chandler, Lawrence Lee & Richard Schwab. (2020) Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea. SLEEP 43:2.
Crossref
Crossref
Rakesh Bhattacharjee. 2020. Sleep Medicine and Mental Health. Sleep Medicine and Mental Health
169
188
.
Huiling Tang, Qiumei Zhu, Wei Li, Siru Qin, Yinan Gong, Hong Wang, Seiji Shioda, Shanshan Li, Jin Huang, Baohu Liu, Yuxin Fang, Yangyang Liu, Shenjun Wang, Yongming Guo, Qing Xia, Yi Guo & Zhifang Xu. (2019) Neurophysiology and Treatment of Disorders of Consciousness Induced by Traumatic Brain Injury: Orexin Signaling as a Potential Therapeutic Target. Current Pharmaceutical Design 25:39, pages 4208-4220.
Crossref
Crossref
Lang Jin, Liang Shi, Ying Zhang, Bei-Bei Chen, Xiao-Li Wang & Yong-Hong Liu. (2019) Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China. Journal of Clinical Neuroscience 63, pages 27-31.
Crossref
Crossref
Michael J. Thorpy, Colin Shapiro, Geert Mayer, Bruce C. Corser, Helene Emsellem, Giuseppe Plazzi, Dan Chen, Lawrence P. Carter, Hao Wang, Yuan Lu, Jed Black & Yves Dauvilliers. (2019) A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Annals of Neurology 85:3, pages 359-370.
Crossref
Crossref
Steven T. Szabo, Michael J. Thorpy, Geert Mayer, John H. Peever & Thomas S. Kilduff. (2019) Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Medicine Reviews 43, pages 23-36.
Crossref
Crossref
Holly Green, Panagiota Tsitsi, Ioanna Markaki, Dag Aarsland & Per Svenningsson. (2019) Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways. CNS Drugs 33:2, pages 143-160.
Crossref
Crossref
P. Philip & P. Sagaspe. 2019. Les Troubles du Sommeil. Les Troubles du Sommeil
91
100
.
Brienne Miner, Nasheena Jiwa & Brian Koo. 2019. Handbook of Sleep Disorders in Medical Conditions. Handbook of Sleep Disorders in Medical Conditions
77
95
.
Samata Singhi, Erin Steinhart & Kiran Maski. 2019. Sleep in Children with Neurodevelopmental Disabilities. Sleep in Children with Neurodevelopmental Disabilities
97
109
.
Philippe Lehert & Bruno Falissard. (2018) Multiple treatment comparison in narcolepsy: a network meta-analysis. Sleep 41:12.
Crossref
Crossref
Michelle G. Baladi, Michael J. Forster, Michael B. Gatch, Richard B. Mailman, Danielle L. Hyman, Lawrence P. Carter & Aaron Janowsky. (2018) Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor. Journal of Pharmacology and Experimental Therapeutics 366:2, pages 367-376.
Crossref
Crossref
Nicholas-Tiberio Economou, Luigi Ferini-Strambi & Paschalis Steiropoulos. (2018) Sleep-Related Drug Therapy in Special Conditions: Children. Sleep Medicine Clinics 13:2, pages 251-262.
Crossref
Crossref
Suresh Kotagal. (2018) Treatment of narcolepsy and other organic hypersomnias in children. Paediatric Respiratory Reviews 25, pages 19-24.
Crossref
Crossref
Tony J. Masri, Vikas Jain & Christian Guilleminault. 2018. Fatigue Management. Fatigue Management
125
140
.
Shinichi Takenoshita & Seiji Nishino. (2017) Pharmacologic Management of Excessive Daytime Sleepiness. Sleep Medicine Clinics 12:3, pages 461-478.
Crossref
Crossref
Chad Ruoff, Richard K. Bogan, Helen Emsellem, Neil Feldman, Alan Lankford, Gary Bream, Moise Khayrallah, Yuan Lu, Lawrence P. Carter & Jed Black. (2017) Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes. Sleep Medicine 35, pages 12-16.
Crossref
Crossref
Maria I. Lapid, Karen M. Kuntz, Sara S. Mason, Jeremiah A. Aakre, Emily S. Lundt, Walter Kremers, Laura A. Allen, Daniel A. Drubach & Bradley F. Boeve. (2017) Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study. Dementia and Geriatric Cognitive Disorders 43:5-6, pages 269-280.
Crossref
Crossref
Andrew D. Krystal & Xavier A. Preud?homme. (2017) Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia. Sleep 40:1.
Crossref
Crossref
Michelle T. Cao & Christian Guilleminault. 2017. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
873
882.e5
.
Mihaela Bazalakova & Ruth M. Benca. 2017. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
462
479.e5
.
Joseph Andrew Berkowski & Anita Valanju Shelgikar. (2016) Disorders of Excessive Daytime Sleepiness Including Narcolepsy and Idiopathic Hypersomnia. Sleep Medicine Clinics 11:3, pages 365-378.
Crossref
Crossref
Chad Ruoff, Todd J. Swick, Robert Doekel, Helene A. Emsellem, Neil T. Feldman, Russell Rosenberg, Gary Bream, Moise A. Khayrallah, Yuan Lu & Jed Black. (2016) Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study. Sleep 39:7, pages 1379-1387.
Crossref
Crossref
Joseph G. Verbalis, Howard Ellison, Mary Hobart, Holly Krasa, John Ouyang, Frank S. Czerwiec, Otis Barnum, Karthikeya Devireddy, Howard Ellison, Miguel Franco, Francis Goldstein, Terrence C. Hack, Kianoosh Kaveh, Ali Khojasteh, John LaFata, Michael J. Lillestol, Sarah Olelewe, David Rosenbaum, Mitchell H. Rosner, Miguel Trevino, Joseph Verbalis & Wayne Wells. (2016) Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT). American Journal of Kidney Diseases 67:6, pages 893-901.
Crossref
Crossref
Terence A. Ketter, Jess Amchin, Mark A. Frye & Nicholas Gross. (2016) Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study. Journal of Affective Disorders 197, pages 51-57.
Crossref
Crossref
Jonathan P. Hintze & Shalini Paruthi. (2016) Sleep in the Pediatric Population. Sleep Medicine Clinics 11:1, pages 91-103.
Crossref
Crossref
Fremonta Meyer, Marlene P. Freeman, Laura Petrillo, Maria Barsky, Thania Galvan, Semmie Kim, Lee Cohen & Hadine Joffe. (2016) Armodafinil for fatigue associated with menopause. Menopause 23:2, pages 209-214.
Crossref
Crossref
Michel Billiard. 2016. Dopamine and Sleep. Dopamine and Sleep
235
253
.
Meredith Broderick & Christian Guilleminault. 2016. Narcolepsy. Narcolepsy
357
368
.
Michael J. Thorpy. 2016. Narcolepsy. Narcolepsy
331
339
.
Seiji Nishino & Nozomu Kotorii. 2016. Narcolepsy. Narcolepsy
285
305
.
Mona Darwish, Mary Bond, Ronghua Yang, Edward T. Hellriegel & Philmore Robertson. (2015) Evaluation of Potential Pharmacokinetic Drug-Drug Interaction Between Armodafinil and Risperidone in Healthy Adults. Clinical Drug Investigation 35:11, pages 725-733.
Crossref
Crossref
Joyce K. Lee‐Iannotti. 2015. Evidence‐Based Neurology: Management of Neurological Disorders. Evidence‐Based Neurology: Management of Neurological Disorders
257
266
.
Brandi R. Page, Edward G. Shaw, Lingyi Lu, David Bryant, David Grisell, Glenn J. Lesser, Drew C. Monitto, Michelle J. Naughton, Stephen R. Rapp, Steven R. Savona, Sunjay Shah, Doug Case & Michael D. Chan. (2015) Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-Oncology 17:10, pages 1393-1401.
Crossref
Crossref
Richard K. Bogan, Neil Feldman, Helene A. Emsellem, Russell Rosenberg, Yuan Lu, Gary Bream, Moise Khayrallah & D. Alan Lankford. (2015) Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy. Sleep Medicine 16:9, pages 1102-1108.
Crossref
Crossref
Zeeshan Khan & Lynn Marie Trotti. (2015) Central Disorders of Hypersomnolence. Chest 148:1, pages 262-273.
Crossref
Crossref
Matthew M. Troester & Rafael Pelayo. (2015) Pediatric Sleep Pharmacology: A Primer. Seminars in Pediatric Neurology 22:2, pages 135-147.
Crossref
Crossref
Mona Darwish, Mary Bond, Ronghua Yang, Edward T. Hellriegel & Philmore RobertsonJr.Jr.. (2015) Evaluation of the Potential for Pharmacokinetic Drug–Drug Interaction Between Armodafinil and Carbamazepine in Healthy Adults. Clinical Therapeutics 37:2, pages 325-337.
Crossref
Crossref
Richard B. Berry & Mary H. Wagner. 2015. Sleep Medicine Pearls. Sleep Medicine Pearls
502
504
.
Richard B. Berry & Mary H. Wagner. 2015. Sleep Medicine Pearls. Sleep Medicine Pearls
477
485
.
Karel Šonka, Peter Šóš & Marek Susta. 2015. Drug Treatment of Sleep Disorders. Drug Treatment of Sleep Disorders
211
229
.
Michel Billiard & Serge Lubin. 2015. Sleep Medicine. Sleep Medicine
541
544
.
Michel Lecendreux. (2014) Pharmacological Management of Narcolepsy and Cataplexy in Pediatric Patients. Pediatric Drugs 16:5, pages 363-372.
Crossref
Crossref
Mona Darwish, Mary Bond, Ronghua Yang, Edward T. Hellriegel & Philmore RobertsonJr.Jr.. (2014) Evaluation of the Potential for a Pharmacokinetic Drug–Drug Interaction Between Armodafinil and Ziprasidone in Healthy Adults. Clinical Drug Investigation 34:10, pages 691-699.
Crossref
Crossref
Felipe Ornell, Samira S. Valvassori, Amanda V. Steckert, Pedro F. Deroza, Wilson R. Resende, Roger B. Varela & João Quevedo. (2014) Modafinil Effects on Behavior and Oxidative Damage Parameters in Brain of Wistar Rats. Behavioural Neurology 2014, pages 1-7.
Crossref
Crossref
Suzanne Wood, Jennifer R. Sage, Tristan Shuman & Stephan G. Anagnostaras. (2013) Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation. Pharmacological Reviews 66:1, pages 193-221.
Crossref
Crossref
Michael T. Saletu & Gerda Saletu-Zyhlarz. 2013. Neuroimaging of Sleep and Sleep Disorders. Neuroimaging of Sleep and Sleep Disorders
231
239
.
. 2013. Neuroimaging of Sleep and Sleep Disorders. Neuroimaging of Sleep and Sleep Disorders
187
415
.
Elyse E. Lower, Atul Malhotra, Victoria Surdulescu & Robert P. Baughman. (2013) Armodafinil for Sarcoidosis-Associated Fatigue: A Double-Blind, Placebo-Controlled, Crossover Trial. Journal of Pain and Symptom Management 45:2, pages 159-169.
Crossref
Crossref
Marc Jobert, Frederick J. Wilson, Thomas Roth, Gé S.F. Ruigt, Peter Anderer & Wilhelmus H.I.M. Drinkenburg. (2013) Guidelines for the Recording and Evaluation of Pharmaco-Sleep Studies in Man: The International Pharmaco-EEG Society (IPEG). Neuropsychobiology 67:3, pages 127-167.
Crossref
Crossref
E.K. St Louis & C. Stephenson. 2013. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms
495
502
.
E.K. St Louis & C. Stephenson. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep
513
519
.
Karel Sonka & Marek Susta. (2012) Diagnosis and management of central hypersomnias. Therapeutic Advances in Neurological Disorders 5:5, pages 297-305.
Crossref
Crossref
Mona Darwish, Mary Bond, Edward T. Hellriegel, James M. Youakim, Ronghua Yang & Philmore Robertson Jr. (2013) Investigation of a Possible Interaction Between Quetiapine and Armodafinil in Patients With Schizophrenia: An Open‐Label, Multiple‐Dose Study. The Journal of Clinical Pharmacology 52:9, pages 1399-1409.
Crossref
Crossref
Jared Bruce, Laura Hancock, Brandon Roberg, Amberly Brown, Erik Henkelman & Sharon Lynch. (2012) Impact of Armodafinil on Cognition in Multiple Sclerosis. Cognitive and Behavioral Neurology 25:3, pages 107-114.
Crossref
Crossref
Dongsoo Kim. (2012) Practical Use and Risk of Modafinil, a Novel Waking Drug. Environmental Health and Toxicology 27, pages e2012007.
Crossref
Crossref
P. Philip & P. Sagaspe. 2012. Les troubles du sommeil. Les troubles du sommeil
117
128
.
Richard B. Berry. 2012. Fundamentals of Sleep Medicine. Fundamentals of Sleep Medicine
451
479
.
Susmita Chowdhuri. 2012. Essentials of Sleep Medicine. Essentials of Sleep Medicine
17
54
.
Imran Ahmed & Michael Thorpy. 2012. Essentials of Sleep Medicine. Essentials of Sleep Medicine
297
314
.
Valérie Cochen De Cock & Yves Dauvilliers. (2011) Current and future therapeutic approaches in narcolepsy. Future Neurology 6:6, pages 771-782.
Crossref
Crossref
Mary Ann Thenganatt & Steven J. Frucht. (2011) Treatment Options for Sleep Dysfunction in Parkinson’s Disease. Current Treatment Options in Neurology 13:5, pages 473-487.
Crossref
Crossref
William V. Bobo, Neil D. Woodward, Min Young Sim, Karuna Jayathilake & Herbert Y. Meltzer. (2011) The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial. Schizophrenia Research 130:1-3, pages 106-113.
Crossref
Crossref
Mona Darwish, Mary Kirby, Edward T. Hellriegel, Ronghua Yang & Philmore RobertsonJrJr. (2011) Systemic Exposure to Armodafinil and Its Tolerability in Healthy Elderly versus Young Men. Drugs & Aging 28:2, pages 139-150.
Crossref
Crossref
Renee Monderer & Michael J. Thorpy. 2011. Sleepiness. Sleepiness
408
420
.
Jamie N. BrownDustin T. Wilson. (2011) Safety and Efficacy of Armodafinil in the Treatment of Excessive Sleepiness. Clinical Medicine Insights: Therapeutics 3, pages CMT.S5124.
Crossref
Crossref
Christian Guilleminault & Vivien C. Abad. 2011. Medicina de los Trastornos del Sue?o. Medicina de los Trastornos del Sue?o
377
396
.
Christian Guilleminault & Michelle T. Cao. 2011. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
957
968
.
Keith A. Wesnes & Helen Brooker. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
423
455
.
Hashir Majid & Max Hirshkowitz. (2010) Therapeutics of Narcolepsy. Sleep Medicine Clinics 5:4, pages 659-673.
Crossref
Crossref
Nils Erik Gilhus, Michael P. Barnes & Michael BraininM. Billiard, Y. Dauvilliers, L. Dolenc‐Grošelj, G.J. Lammers, G. Mayer & K. Sonka. 2010. European Handbook of Neurological Management. European Handbook of Neurological Management
513
528
.
Michael Silber, Lois Krahn & Timothy Morgenthaler. 2010. Sleep Medicine in Clinical Practice, Second Edition. Sleep Medicine in Clinical Practice, Second Edition
68
88
.
Ji Zhang & Jason Crawford. 2010. Modern Drug Synthesis. Modern Drug Synthesis
291
305
.
Russell P. Rosenberg, Richard K. Bogan, Jane M. Tiller, Ronghua Yang, James M. Youakim, Craig Q. Earl & Thomas Roth. (2010) A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Armodafinil for Excessive Sleepiness Associated With Jet Lag Disorder. Mayo Clinic Proceedings 85:7, pages 630-638.
Crossref
Crossref
Imran Ahmed & Michael Thorpy. (2010) Clinical Features, Diagnosis and Treatment of Narcolepsy. Clinics in Chest Medicine 31:2, pages 371-381.
Crossref
Crossref
Michelle Cao. (2010) Advances in Narcolepsy. Medical Clinics of North America 94:3, pages 541-555.
Crossref
Crossref
M. I. Boulos & B. J. Murray. (2014) Current Evaluation and Management of Excessive Daytime Sleepiness. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37:2, pages 167-176.
Crossref
Crossref
Jefferson B. Prince & Timothy E. Wilens. 2010. Comorbilidades del TDAH. Comorbilidades del TDAH
339
384
.
Meredith Broderick & Christian Guilleminault. 2010. Narcolepsy. Narcolepsy
301
311
.
Michael Thorpy. 2010. Narcolepsy. Narcolepsy
287
294
.
Seiji Nishino & Nozomu Kotorii. 2010. Narcolepsy. Narcolepsy
251
265
.
LE LundorffBH Jønsson & P. Sjøgren. (2009) Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliative Medicine 23:8, pages 731-738.
Crossref
Crossref
Charles A. Czeisler, James K. Walsh, Keith A. Wesnes, Thomas Roth & Sanjay Arora. (2009) Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study. Mayo Clinic Proceedings 84:11, pages 958-972.
Crossref
Crossref
Mortimer Mamelak. (2009) Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Progress in Neurobiology 89:2, pages 193-219.
Crossref
Crossref
Mona Darwish, Mary Kirby & Edward T. Hellriegel. (2009) Comparison of Steady-State Plasma Concentrations of Armodafinil and Modafinil Late in the Day Following Morning Administration. Clinical Drug Investigation 29:9, pages 601-612.
Crossref
Crossref
Mona Darwish, Mary Kirby, Edward T. Hellriegel & Philmore RobertsonJrJr. (2009) Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives. Clinical Drug Investigation 29:9, pages 613-623.
Crossref
Crossref
Karly P. Garnock-Jones, Sohita Dhillon & Lesley J. Scott. (2009) Armodafinil. CNS Drugs 23:9, pages 793-803.
Crossref
Crossref
Michael Saletu, Peter Anderer, Gerda Maria Saletu-Zyhlarz, Magdalena Mandl, Bernd Saletu & Josef Zeitlhofer. (2009) Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: Double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). Sleep Medicine 10:8, pages 850-858.
Crossref
Crossref
Christopher J. Edgar, Edward F. Pace‐Schott & Keith A. Wesnes. (2009) Approaches to measuring the effects of wake‐promoting drugs: a focus on cognitive function. Human Psychopharmacology: Clinical and Experimental 24:5, pages 371-389.
Crossref
Crossref
Elaine M. Fiocchi, Yin-Guo Lin, Lisa Aimone, John A. Gruner & Dorothy G. Flood. (2009) Armodafinil promotes wakefulness and activates Fos in rat brain. Pharmacology Biochemistry and Behavior 92:3, pages 549-557.
Crossref
Crossref
Michael Russo. (2009) Pharmacotherapy of Excessive Sleepiness: Focus on Armodafinil. Clinical Medicine. Therapeutics 1, pages CMT.S1994.
Crossref
Crossref
Mona Darwish, Mary Kirby, Edward T Hellriegel, Ronghua Yang & Philmore RobertsonJrJr. (2009) Pharmacokinetic Profile of Armodafinil in Healthy Subjects. Clinical Drug Investigation 29:2, pages 87-100.
Crossref
Crossref
Christian Guilleminault & Vivien C. Abad. 2009. Sleep Disorders Medicine. Sleep Disorders Medicine
377
396
.
Michael J Minzenberg & Cameron S Carter. (2007) Modafinil: A Review of Neurochemical Actions and Effects on Cognition. Neuropsychopharmacology 33:7, pages 1477-1502.
Crossref
Crossref
Kristin L. Bigos, Marci L. Chew & Robert R. Bies. (2008) Pharmacokinetics in geriatric psychiatry. Current Psychiatry Reports 10:1, pages 30-36.
Crossref
Crossref
Thomas Roth, Gregory A. Rippon & Sanjay Arora. (2007) Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Sleep and Breathing 12:1, pages 53-62.
Crossref
Crossref
Luca Vignatelli, Roberto D'Alessandro & Livia Candelise. (2008) Antidepressant drugs for narcolepsy. Cochrane Database of Systematic Reviews 2010:6.
Crossref
Crossref
Mona Darwish, Mary Kirby, Philmore RobertsonJrJr & Edward T Hellriegel. (2008) Interaction Profile of Armodafinil with Medications Metabolized by Cytochrome P450 Enzymes 1A2, 3A4 and 2C19 in Healthy Subjects. Clinical Pharmacokinetics 47:1, pages 61-74.
Crossref
Crossref
Susan Keam & Matthew C Walker. (2007) Therapies for narcolepsy with or without cataplexy: evidence-based review. Current Opinion in Neurology 20:6, pages 699-703.
Crossref
Crossref
Michael J. Thorpy. (2007) NARCOLEPSY. CONTINUUM: Lifelong Learning in Neurology 13, pages 101-114.
Crossref
Crossref
Milton K. Erman. (2006) Selected Sleep Disorders: Restless Legs Syndrome and Periodic Limb Movement Disorder, Sleep Apnea Syndrome, and Narcolepsy. Psychiatric Clinics of North America 29:4, pages 947-967.
Crossref
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:12.
Crossref
Crossref
Jonathan RL Schwartz. (2006) Emerging treatment options for excessive sleepiness associated with narcolepsy. Therapy 3:3, pages 375-382.
Crossref
Crossref